Hawaii Senate Bill SCR90

Hawaii 2024 Regular Session

• Introduced: 3/8/24
• Refer: 3/14/24

Caption

Requesting The Auditor To Assess Both The Social And Financial Effects Of Proposed Mandated Health Insurance Coverage For A Percentage Of The Costs Of Ketamine Therapy To Treat Depression And Suicide Ideation.

Impact

The assessment mandated by SCR90 will focus on determining both the social benefits and financial implications of enforcing such insurance coverage. This involves exploring how covering ketamine therapy might improve treatment options for state residents struggling with mental health disorders, particularly for those who are resistant to other treatment methods. By positioning the Auditor to evaluate these factors, the resolution aims to provide a solid foundation for subsequent legislation concerning mental health care in Hawaii.

Summary

SCR90 is a Senate Concurrent Resolution from the State of Hawaii that requests an assessment by the Auditor regarding the social and financial implications of mandated health insurance coverage for ketamine therapy. This resolution arises in the context of proposed Senate Bill No. 279, which aims to ensure insurance coverage for a percentage of the costs associated with ketamine therapy, specifically for treating depression and suicide ideation. Recognizing the growing mental health crisis, SCR90 seeks to facilitate deeper analysis before any legislative measures can be enacted.

Contention

Debates surrounding SCR90 may highlight varying perspectives on mandated health insurance coverage. Advocates for mental health improvement may argue for the necessity of the legislation, citing the effectiveness of ketamine as a treatment for severe depression. Conversely, opponents may raise concerns over the financial burden such mandates could impose on insurance providers and the potential for increased premiums. As such, additional scrutiny will be necessary to balance healthcare accessibility with economic implications for the insurance system.